High Court 'Skinny Label' Case Will Matter To Tech Litigators
On April 29, the U.S. Supreme Court will hear oral argument in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma Inc., a case involving induced infringement.[1]...To view the full article, register now.
Already a subscriber? Click here to view full article